[Treatment of nephritis in systemic lupus erythematodes].
Ligtenberg
G
G
Afd. Nierziekten en Hypertensie, Academisch Ziekenhuis, Utrecht.
Derksen
R H
RH
Berden
J H
JH
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001706:Biopsy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007678:Kidney Glomerulus / Q000473:pathology; D008181:Lupus Nephritis / Q000188:drug therapy* / Q000473:pathology; D008775:Methylprednisolone / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D008775:Methylprednisolone